[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566975":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":31,"locations":36,"responsibleParty":238,"collaborators":240,"id":242,"slug":243,"hasResults":244,"nctId":245,"briefTitle":246,"officialTitle":247,"acronym":248,"eligibilityCriteria":249,"healthyVolunteers":244,"sex":250,"minAge":251,"maxAge":25,"enrollmentInfo":252,"targetDuration":25,"studyType":255,"phases":256,"briefSummary":258,"conditions":259,"keywords":264,"overallStatus":39,"whyStopped":25,"lastUpdateSubmitDate":268,"lastUpdatePostDateStruct":269,"startDateStruct":272,"completionDateStruct":274,"leadSponsor":276,"locationsCount":277},{"fullName":5,"class":6},"i-Lumen Scientific AUS PTY LTD","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active i-Lumen AMD therapy","EXPERIMENTAL","Active transpalpebral microcurrent therapy",[13],"Device: i-Lumen AMD",{"label":15,"type":16,"description":17,"interventionNames":18},"Sham i-Lumen AMD therapy","SHAM_COMPARATOR","Sham transpalpebral microcurrent therapy",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","i-Lumen AMD","i-Lumen AMD transpalpebral microcurrent stimulation system",[9,15],null,[27],{"name":28,"affiliation":29,"role":30},"Meredith Mundy","i-Lumen Scientific, Inc.","STUDY_DIRECTOR",[32],{"name":28,"role":33,"phone":34,"phoneExt":25,"email":35},"CONTACT","408-440-7049","mmundy@i-lumen.com",[37,59,76,91,109,126,142,154,173,190,206,222],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Retina Consultants San Diego","RECRUITING","Poway","California","92064","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-117.03586,32.96282,{"lat":49,"lon":48},[52,56],{"name":53,"role":33,"phone":54,"phoneExt":25,"email":55},"Research Coordinator","858-451-1911","dcarbajal@rcsd.com",{"name":57,"role":58,"phone":25,"phoneExt":25,"email":25},"Nicholas London, MD","PRINCIPAL_INVESTIGATOR",{"facility":60,"status":39,"city":61,"state":62,"zip":63,"country":43,"countryCode":44,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"Retina Consultants PC","Manchester","Connecticut","06042",{"type":46,"coordinates":65},[66,67],-72.52148,41.77593,{"lat":67,"lon":66},[70,74],{"name":71,"role":33,"phone":72,"phoneExt":25,"email":73},"Chris Research Coordinator","860-646-7704 x113","cdwy@retinact.com",{"name":75,"role":58,"phone":25,"phoneExt":25,"email":25},"Noam Rudnick, MD",{"facility":77,"status":39,"city":78,"state":79,"zip":80,"country":43,"countryCode":44,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"University Retina & Macula Associates","Lemont","Illinois","60439",{"type":46,"coordinates":82},[83,84],-88.00173,41.67364,{"lat":84,"lon":83},[87],{"name":88,"role":33,"phone":89,"phoneExt":25,"email":90},"Clinical Research Manager","708-765-4110","swheatley@uretina.com",{"facility":92,"status":93,"city":94,"state":95,"zip":96,"country":43,"countryCode":44,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"Sierra Eye Associates","NOT_YET_RECRUITING","Reno","Nevada","89502",{"type":46,"coordinates":98},[99,100],-119.8138,39.52963,{"lat":100,"lon":99},[103,107],{"name":104,"role":33,"phone":105,"phoneExt":25,"email":106},"Mandi Research Coordinator","775-329-0286","mseverson@sierraeyeassociates.com",{"name":108,"role":58,"phone":25,"phoneExt":25,"email":25},"Arshad Khanani",{"facility":110,"status":39,"city":111,"state":112,"zip":113,"country":43,"countryCode":44,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Texas Retina Associates","Fort Worth","Texas","76104",{"type":46,"coordinates":115},[116,117],-97.32085,32.72541,{"lat":117,"lon":116},[120,124],{"name":121,"role":33,"phone":122,"phoneExt":25,"email":123},"Lori Research Coordinator","817-334-0882 x411","lmullen@texasretina.com",{"name":125,"role":58,"phone":25,"phoneExt":25,"email":25},"Patrick Williams, MD",{"facility":127,"status":39,"city":128,"state":112,"zip":129,"country":43,"countryCode":44,"cosmosGeoPoint":130,"geoPoint":134,"contacts":135},"Tyler Retina Research Insitute","Tyler","75703",{"type":46,"coordinates":131},[132,133],-95.30106,32.35126,{"lat":133,"lon":132},[136,140],{"name":137,"role":33,"phone":138,"phoneExt":25,"email":139},"Melissa Long Research Coordinator","903-597-4644","mlong@tylerretina.com",{"name":141,"role":58,"phone":25,"phoneExt":25,"email":25},"Samuel Minaker, MD",{"facility":143,"status":144,"city":145,"state":146,"zip":25,"country":147,"countryCode":148,"cosmosGeoPoint":149,"geoPoint":153,"contacts":25},"Cerulea","ACTIVE_NOT_RECRUITING","East Melbourne","Victoria","Australia","AU",{"type":46,"coordinates":150},[151,152],144.9879,-37.81667,{"lat":152,"lon":151},{"facility":155,"status":39,"city":156,"state":157,"zip":158,"country":159,"countryCode":160,"cosmosGeoPoint":161,"geoPoint":165,"contacts":166},"Auckland Eye Limited","Remuera","Auckland","1050","New Zealand","NZ",{"type":46,"coordinates":162},[163,164],174.79819,-36.88041,{"lat":164,"lon":163},[167,171],{"name":168,"role":33,"phone":169,"phoneExt":25,"email":170},"Alice Research Coordinator","64 09 529 2480","Alice@aucklandeye.co.nz",{"name":172,"role":58,"phone":25,"phoneExt":25,"email":25},"Riyaz Bhikoo",{"facility":174,"status":39,"city":175,"state":25,"zip":25,"country":176,"countryCode":177,"cosmosGeoPoint":178,"geoPoint":182,"contacts":183},"Queens University Belfast \u002F Belfast City Hospital","Belfast","United Kingdom","UK",{"type":46,"coordinates":179},[180,181],-5.92541,54.59682,{"lat":181,"lon":180},[184,188],{"name":185,"role":33,"phone":186,"phoneExt":25,"email":187},"Therese Research Coordinator","+44 02895 040342","t.kearney@qub.ac.uk",{"name":189,"role":58,"phone":25,"phoneExt":25,"email":25},"Tunde Peto",{"facility":191,"status":39,"city":192,"state":25,"zip":193,"country":176,"countryCode":177,"cosmosGeoPoint":194,"geoPoint":198,"contacts":199},"King's College Hospital","London","SE5 9RS",{"type":46,"coordinates":195},[196,197],-0.12574,51.50853,{"lat":197,"lon":196},[200,204],{"name":201,"role":33,"phone":202,"phoneExt":25,"email":203},"Nikki Research Coordinator","+44 203 299 7791","noimottimson@nhs.net",{"name":205,"role":58,"phone":25,"phoneExt":25,"email":25},"Timothy Jackson, PhD, FRCOphth",{"facility":207,"status":39,"city":208,"state":25,"zip":209,"country":176,"countryCode":177,"cosmosGeoPoint":210,"geoPoint":214,"contacts":215},"London North West University Healthcare","Middlesex","HA1 3UJ",{"type":46,"coordinates":211},[212,213],-0.26856,51.53174,{"lat":213,"lon":212},[216,220],{"name":217,"role":33,"phone":218,"phoneExt":25,"email":219},"Sandali Research Coordinator","+44 (0) 208 453 2077","snammuniarachchge@nhs.net",{"name":221,"role":58,"phone":25,"phoneExt":25,"email":25},"Christiana Dinah, BSc, MB BS, MRes, FRCOphth",{"facility":223,"status":39,"city":224,"state":25,"zip":225,"country":176,"countryCode":177,"cosmosGeoPoint":226,"geoPoint":230,"contacts":231},"Sunderland Eye Infirmary","Sunderland","SR2 9HP",{"type":46,"coordinates":227},[228,229],-1.38222,54.90465,{"lat":229,"lon":228},[232,236],{"name":233,"role":33,"phone":234,"phoneExt":25,"email":235},"SEI Research Nurses Research Coordinator","0191 5699074","stsft.seiresearchnurses@nhs.net",{"name":237,"role":58,"phone":25,"phoneExt":25,"email":25},"Ajay Kotagiri",{"type":239,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[241],{"name":29,"class":6},"100566975","microcurrent-stimulation-therapy-for-intermediate-to-advanced-nonexudative-age-related-macular-degeneration-100566975",false,"NCT06662162","Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration","Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration (i-SIGHT2): a Multicentre, Randomised, Sham-controlled, Double-masked, Clinical Device Trial.","i-SIGHT2","Key Inclusion Criteria:\n\n* Presence of at least one large druse \\>125 microns in diameter due to AMD.\n* BCVA letter score of 35 to 70 letters (inclusive) (Snellen equivalent 6\u002F12 to 6\u002F60 \\[20\u002F40 to 20\u002F200\\])\n\nKey Exclusion Criteria:\n\n* Any implanted electrical device(s) including deep brain stimulator, hearing or visual implants (i.e., cochlear implant, auditory brainstem implant, retinal prostheses), and\u002For cardiac defibrillator\u002Fpacemaker.\n* Implanted metallic device within 20 cm of the Treatment electrode (study eye(s)) and\u002For the grounding electrode (base of the hairline on the back of the neck).\n* Uncontrolled diabetes, defined as glycated haemoglobin (HbA1c) \\>10% (13.3 mmol\u002FL).\n* Current tobacco or tobacco-related product use or history within the past 5 years of heavy smoking (defined as, on average, more than half a pack of cigarettes per day).\n* Known severe allergy to fluorescein dye.\n* Medical diagnosis of severe dry eye defined as requiring either artificial tears more than six (6) times a day or prescription drops (i.e., Restasis, Xiidra, or Cequa).\n* History of seizure disorders, chronic migraines and\u002For cluster headaches.\n* History and\u002For evidence of diabetic retinopathy in either eye as assessed by CF, fundus fluorescein angiography (FA), and OCT, to be confirmed by the Central Reading Centre.\n* Other conditions which pre-dispose to chorioretinal atrophy such as inherited retinal dystrophy (i.e., Stargardt's disease, Best's disease, pattern dystrophy, central areolar choroidal dystrophy, etc.).\n* History and\u002For evidence of exudative AMD in the study eye as assessed by CF, FA (or OCT-A ), and OCT, to be confirmed by Central Reading Centre.\n* GA involving the foveal centre, as assessed by the Central Reading Centre using AF and OCT.\n* History of intravitreal injections for GA (e.g., Syfovre or Izervay).\n* Treatment with photobiomodulation (PBM) therapy or short pulse laser within 12 months prior to screening.\n* Glaucoma requiring ≥3 medications and\u002For drops per day, or history of trabeculectomy.\n* History of any kind of intraocular surgery, excluding cataract surgery performed ≥3 months from Screening.\n* History of yttrium aluminium garnet (YAG) laser posterior capsulotomy \\\u003C1 month from Screening.\n* Visually significant cataracts and\u002For visually significant posterior capsular opacification.\n* History of amblyopia.","ALL","60 Years",{"count":253,"type":254},100,"ESTIMATED","INTERVENTIONAL",[257],"NA","The goal of this clinical trial is to characterize the safety and effectiveness of the i-Lumen AMD transpalpebral microcurrent device and therapy in patients with intermediate to advanced nonexudative AMD.\n\nParticipants will:\n\n* Undergo an initial loading regimen, followed by 7 maintenance over the course of 11 months.\n* Participants will return monthly through Month 14 (3 months post-last treatment) for evaluation and monitoring.",[260,261,262,263],"Age-Related Macular Degeneration","Age-related Macular Degeneration (ARMD)","Intermediate AMD","Geographic Atrophy Secondary to Age-related Macular Degeneration",[265,262,266,267],"AMD","Dry AMD","Geographic Atrophy","2026-08-07",{"date":270,"type":271},"2026-08-11","ACTUAL",{"date":273,"type":271},"2025-05-07",{"date":275,"type":254},"2029-12-31",{"name":5,"class":6},12]